
The SPRAVATO® Story with Dr. Hussesini K. Manji,
Psychiatry Tomorrow
00:00
Intro
This chapter explores the approval of esketamine as a transformative medication for treatment-resistant depression, examining its effects on psychiatry and mental health care. It delves into the science behind its action, the FDA approval process, and the challenges faced in its development.
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.